Albumin (mouse, rat) KQIKKQTAL-amide
Description
Application Data
Description
-
Peptide from blood plasma transport protein
Application Data
-
Catalogue number crb1000346 Molecular Weight 1055.7 Sequence (one letter code) KQIKKQTAL-amide Sequence (three letter code) H-Lys-Gln-Ile-Lys-Lys-Gln-Thr-Ala-Leu-NH2 Molecular Weight 1055.7 Purity >95% References Jun et al., (2017). Increase in serum albumin concentration is associated with prediabetes development and progression to overt diabetes independently of metabolic syndrome. PLoS One. 12(4): e0176209. PMID: 28430803
Kawai et al., (2018). Association between serum albumin level and incidence of end-stage renal disease in patients with Immunoglobulin A nephropathy: A possible role of albumin as an antioxidant agent. PLoS One. 13(5): e0196655. PMID: 29795559
Albumin is a family of globular, water soluble, un-glycosylated proteins commonly found in blood plasma. Albumins generally act as transport proteins that bind to various ligands to transport them around.
The most common member of this family is serum albumin. Serum albumin is produced by the liver and is the most abundant plasma protein, it provides oncotic pressure, transports bilirubin, steroids, fatty acids, thyroid hormones and other hormones, and serves as an extracellular antioxidant agent.
Too much or too little circulating serum albumin may be harmful. Perturbations in serum albumin concentration is associated with both type 2 diabetes and metabolic syndrome (MetS). Increase in serum albumin concentration might protect against early glycemic deterioration and progression to type 2 diabetes even in subjects without MetS. Albumin in the urine usually denotes the presence of kidney disease.